Evrys Bio
PrivateLast Round
VC Round
May 4, 2022
Total Funding Raised
$78.47M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Evrys Bio is a biotechnology company developing host-directed, broad-spectrum small-molecule antiviral drugs that modulate human sirtuin enzymes to enhance intrinsic cellular antiviral defenses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evrys Bio Comparables
Compare Evrys Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthLinks Bio | 76% | |
| Selva Therapeutics | 74% | |
| Cocrystal Pharma Inc | 73% |
Evrys Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 4, 2022 | ||||
| Grant | Nov 23, 2021 | ||||
| Grant | Jul 13, 2021 | ||||
| Grant | Aug 27, 2020 | ||||
| Grant | Jul 31, 2019 | ||||
VC Round | Dec 1, 2017 |
Evrys Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Benjamin Franklin Technology Partners | Series A Extension, VC Round |
| United States Department of Defense | Grant |
| Keiretsu Forum | VC Round |
| U.S. Department of Defense | Grant |
| NIH RADx | Grant |
| Pennsylvania Department of Community and Economic Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 71% MoM, reaching 1.5K.
- Jun 18, 2026
Monthly visitors grew 70% MoM, reaching 1.1K.
Evrys Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evrys Bio's valuation, stock price, and market status.
Is Evrys Bio a public or private company?
Evrys Bio is a private company.
What is the current stock price of Evrys Bio?
Evrys Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Evrys Bio worth (valuation)?
Valuation information for Evrys Bio is not publicly available.
Can I buy Evrys Bio stock?
Evrys Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evrys Bio's last funding round?
Evrys Bio's most recent funding round was VC Round on May 4, 2022.
Who are the main investors in Evrys Bio?
Key investors in Evrys Bio include United States Department of Defense.
Will Evrys Bio IPO soon?
No public IPO plans have been announced for Evrys Bio.
How can I track Evrys Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evrys Bio's secondary market activity and sign up for updates.